Wu Du
16Patents
2h-index
49Co-inventors
54Inventor score
Filing activity: Apr 12, 2001 → Aug 20, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6372906B1 | Synthesis of silyl camptothecins and silyl homocamptothecins | Chemistry; Metallurgy | 3 | Expired |
| US10370371B2 | Substituted pyrimidine Bmi-1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10428050B2 | Substituted reverse pyrimidine Bmi-1 inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11891379B2 | Deuterated Defactinib compound and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10584115B2 | Substituted pyridine and pyrazine BMI-1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11753392B2 | Method for synthesis of deuterated amide and deuterated sulfonamide | Chemistry; Metallurgy | 0 | Active |
| US11591301B2 | Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereof | Chemistry; Metallurgy | 0 | Active |
| US7064206B1 | Highly lipophilic camptothecin intermediates and prodrugs and methods of preparation thereof | Chemistry; Metallurgy | 0 | Expired |
| US12194040B2 | FAK inhibitor and drug combination thereof | Chemistry; Metallurgy | 0 | Active |
| US11447477B2 | Indoleamine-2,3-dioxygenase inhibitor, the preparative method and the use thereof | Chemistry; Metallurgy | 0 | Active |
| US11926618B2 | Halogen-substituted phenylate compound and applications thereof | Chemistry; Metallurgy | 0 | Active |
| US9975878B2 | Substituted triazine BMI-1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9650395B2 | Antibacterial compounds and methods for use | Emerging Cross-Sectional Technologies | 0 | Active |
| US10450274B2 | Quinoline compounds, preparation methods thereof, and uses thereof as urate transporter inhibitor drug | Chemistry; Metallurgy | 0 | Active |
| US7064202B1 | Camptothecin intermediates and prodrugs and methods of preparation thereof | Chemistry; Metallurgy | 0 | Expired |
| US11180483B2 | Substituted reverse pyrimidine Bmi-1 inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.